These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33922903)

  • 1. Antiplatelet Activity of Isorhamnetin via Mitochondrial Regulation.
    Rodríguez L; Badimon L; Méndez D; Padró T; Vilahur G; Peña E; Carrasco B; Vogel H; Palomo I; Fuentes E
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33922903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels.
    Méndez D; Arauna D; Fuentes F; Araya-Maturana R; Palomo I; Alarcón M; Sebastián D; Zorzano A; Fuentes E
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of antiplatelet ortho-carbonyl hydroquinones with differential action on platelet aggregation stimulated by collagen or TRAP-6.
    Méndez D; Urra FA; Millas-Vargas JP; Alarcón M; Rodríguez-Lavado J; Palomo I; Trostchansky A; Araya-Maturana R; Fuentes E
    Eur J Med Chem; 2020 Apr; 192():112187. PubMed ID: 32155530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhamnetin as a potential therapeutic agent for diabetes mellitus through PGK1/AKT activation.
    Alqudah A; Qnais E; Alqudah M; Gammoh O; Wedyan M; Abdalla SS
    Arch Physiol Biochem; 2024 Mar; ():1-11. PubMed ID: 38445617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it.
    Duan J; Xie Y; Luo H; Li G; Wu T; Zhang T
    Food Chem Toxicol; 2014 Apr; 66():313-20. PubMed ID: 24525098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation.
    Fuentes E; Badimon L; Caballero J; Padró T; Vilahur G; Alarcón M; Pérez P; Palomo I
    Thromb Haemost; 2014 Mar; 111(3):491-507. PubMed ID: 24306059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet and Anticoagulant Activity of Isorhamnetin and Its Derivatives Isolated from Sea Buckthorn Berries, Measured in Whole Blood.
    Stochmal A; Rolnik A; Skalski B; Zuchowski J; Olas B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects.
    Stainer AR; Sasikumar P; Bye AP; Unsworth AJ; Holbrook LM; Tindall M; Lovegrove JA; Gibbins JM
    TH Open; 2019 Jul; 3(3):e244-e258. PubMed ID: 31367693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of acylhydroquinone derivatives as potent antiplatelet agents.
    Méndez D; Donoso-Bustamante V; Pablo Millas-Vargas J; Pessoa-Mahana H; Araya-Maturana R; Fuentes E
    Biochem Pharmacol; 2021 Jan; 183():114341. PubMed ID: 33197432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx.
    Shah BH; Nawaz Z; Virani SS; Ali IQ; Saeed SA; Gilani AH
    Biochem Pharmacol; 1998 Oct; 56(8):955-60. PubMed ID: 9776305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat-lowering effects of isorhamnetin are via NHR-49-dependent pathway in
    Farias-Pereira R; Savarese J; Yue Y; Lee SH; Park Y
    Curr Res Food Sci; 2020 Jun; 2():70-76. PubMed ID: 32914113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels.
    Cho MR; Park JW; Jung IS; Yi KY; Yoo SE; Chung HJ; Yun YP; Kwon SH; Shin HS
    Arch Pharm Res; 2005 Jan; 28(1):61-7. PubMed ID: 15742810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
    Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet activity of obovatol, a biphenolic component of Magnolia Obovata, in rat arterial thrombosis and rabbit platelet aggregation.
    Park ES; Lim Y; Lee SH; Kwon BM; Yoo HS; Hong JT; Yun YP
    J Atheroscler Thromb; 2011; 18(8):659-69. PubMed ID: 21512279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
    Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
    Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.